The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic…
Alfa Cytology announced its pancreatic cancer research services for anticancer therapy in the early preclinical stages. Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research…
Alfa Cytology announced its pancreatic cancer research services for anticancer therapy in the early preclinical stages. Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research…
The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic…
CD BioSciences, a prominent biotech company, has recently unveiled its latest and innovative service on cytoskeleton-based tumor marker development. This groundbreaking service can be utilized for preclinical tests to determine…
Recently, CD BioSciences has announced the release of marine drug development services aiming to move forward the frontier of this area. Utilizing cutting-edge marine biological analysis techniques and unique platforms,…
Creative BioMart, a leading manufacturer of recombinant proteins, announced today the expansion of its product offerings to include recombinant coagulation factor III (F3) protein. This new addition to the company’s…
Our website uses cookies to provide you the best experience. However, by continuing to use our website, you agree to our use of cookies. For more information, read our Cookie Policy.